Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma

R. Bílek, T. Zelinka, P. Vlček, J. Dušková, D. Michalský, K. Novák, E. Václavíková, J. Widimský

. 2017 ; 66 (Supplementum 3) : S397-S408. [pub] 2017Sep26
. 2017 ; () : S397-S408.

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19030498

This work discusses the clinical performance of chromogranin A, free metanephrine and normetanephrine determination in plasma using a radioimmunoanalytical methods for the diagnosis of pheochromocytoma and paraganglioma. Blood samples were collected from 55 patients (46 pheochromocytomas, 9 paragangliomas). A sampling of biological materials was performed preoperatively and about one week, six months and one year after adrenal gland surgery. The comparative group without a diagnosis of pheochromocytoma/paraganglioma consisted of 36 pheochromocytoma/paraganglioma patients more than 4 months after adrenal gland surgery, and of 87 patients, 16 of them with multiple endocrine neoplasia, 9 with medullary and 5 with parafolicullar carcinoma of the thyroid gland. The rest were patients with various adrenal gland disorders. Chromogranin A, metanephrine and normetanephrine were determined in the EDTA-plasma using a radioimmunoassay kits Cisbio Bioassays, France and IBL International GmbH, Germany. Clinical sensitivity was 96 % for the combination of metanephrine and normetanephrine, and 93 % for chromogranin A. Clinical specificity was 100 % for the combination metanephrine and normetanephrine, and 96 % for chromogranin A. Falsely elevated levels of chromogranin A were observed in 1 patient with chronic renal insufficiency and 9 analyses were influenced by the administration of proton pump inhibitors. These results were excluded of CGA specificity. Both the combination of plasma free metanephrine, normetanephrine and chromogranin A as determined by radioimmunoassays, which are simple without the necessity of special laboratory material, are effective markers of pheochromocytoma or paraganglioma. Chromogranin A exerts association to malignity and all markers are associated with tumor mass.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19030498
003      
CZ-PrNML
005      
20200309150615.0
007      
ta
008      
190830s2017 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933719 $2 doi
035    __
$a (PubMed)28948824
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Bílek, Radovan, $d 1954- $7 jo20000074070 $u Institute of Endocrinology, Prague, Czech Republic
245    10
$a Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma / $c R. Bílek, T. Zelinka, P. Vlček, J. Dušková, D. Michalský, K. Novák, E. Václavíková, J. Widimský
520    9_
$a This work discusses the clinical performance of chromogranin A, free metanephrine and normetanephrine determination in plasma using a radioimmunoanalytical methods for the diagnosis of pheochromocytoma and paraganglioma. Blood samples were collected from 55 patients (46 pheochromocytomas, 9 paragangliomas). A sampling of biological materials was performed preoperatively and about one week, six months and one year after adrenal gland surgery. The comparative group without a diagnosis of pheochromocytoma/paraganglioma consisted of 36 pheochromocytoma/paraganglioma patients more than 4 months after adrenal gland surgery, and of 87 patients, 16 of them with multiple endocrine neoplasia, 9 with medullary and 5 with parafolicullar carcinoma of the thyroid gland. The rest were patients with various adrenal gland disorders. Chromogranin A, metanephrine and normetanephrine were determined in the EDTA-plasma using a radioimmunoassay kits Cisbio Bioassays, France and IBL International GmbH, Germany. Clinical sensitivity was 96 % for the combination of metanephrine and normetanephrine, and 93 % for chromogranin A. Clinical specificity was 100 % for the combination metanephrine and normetanephrine, and 96 % for chromogranin A. Falsely elevated levels of chromogranin A were observed in 1 patient with chronic renal insufficiency and 9 analyses were influenced by the administration of proton pump inhibitors. These results were excluded of CGA specificity. Both the combination of plasma free metanephrine, normetanephrine and chromogranin A as determined by radioimmunoassays, which are simple without the necessity of special laboratory material, are effective markers of pheochromocytoma or paraganglioma. Chromogranin A exerts association to malignity and all markers are associated with tumor mass.
650    _2
$a mladiství $7 D000293
650    _2
$a nádory nadledvin $x krev $x diagnóza $7 D000310
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a nádorové biomarkery $x krev $7 D014408
650    _2
$a chromogranin A $x krev $7 D053379
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metanefrin $x krev $7 D008676
650    _2
$a lidé středního věku $7 D008875
650    _2
$a normetanefrin $x krev $7 D009647
650    _2
$a feochromocytom $x krev $x diagnóza $7 D010673
650    _2
$a radioimunoanalýza $x metody $7 D011863
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zelinka, Tomáš $7 xx0074465 $u Center for Hypertension, Third Medical Department – Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Vlček, Petr, $d 1961- $7 xx0003505 $u Department of Nuclear Medicine and Endocrinology, Faculty Hospital Motol and Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Dušková, Jaroslava, $d 1952- $7 jo2002104714 $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Michalský, David $7 xx0091243 $u First Department of Surgery – Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Novák, Květoslav, $d 1966- $7 xx0063922 $u Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Václavíková, Eliška $7 xx0228492 $u Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Widimský, Jiří, $d 1956- $7 jn99240001422 $u Center for Hypertension, Third Medical Department – Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, Supplementum 3 (2017), s. S397-S408
773    0_
$t Institute of Endocrinology - 60th anniversary $g (2017), s. S397-S408 $w MED00200905
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28948824 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20190830 $b ABA008
991    __
$a 20200309151032 $b ABA008
999    __
$a ok $b bmc $g 1440134 $s 1068986
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 66 $c Supplementum 3 $d S397-S408 $e 2017Sep26 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2017 $d S397-S408 $m Institute of Endocrinology - 60th anniversary $x MED00200905
LZP    __
$b NLK118 $a Pubmed-20190830

Find record

Citation metrics

Archiving options